Immunoprecise Antibodies Ltd (IPA) — Cash Flow Quality Index
Immunoprecise Antibodies Ltd (IPA) has a Cash Flow Quality Index of 0.11x as of October 2016. Operating cash flow of $11.17K is below net income of $101.16K, suggesting accrual-heavy earnings not yet converted to cash. Explore IPA debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Immunoprecise Antibodies Ltd Cash Flow Quality Index (2006–2016)
Historical Cash Flow Quality Index for Immunoprecise Antibodies Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Immunoprecise Antibodies Ltd (IPA) cash conversion ratio.
Annual Cash Flow Quality Index for Immunoprecise Antibodies Ltd (2006–2016)
Year-by-year earnings quality comparison for Immunoprecise Antibodies Ltd.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | 1.88x | $284.09K | $151.03K | ▲ +380.3% |
| 2014 | -0.67x | $-46.60K | $69.44K | ▼ -1.0% |
| 2006 | -0.66x | $-110.59K | $166.48K | — |